Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer.
about
Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Population pharmacokinetic and ...... udies in patients with cancer.
@en
Population pharmacokinetic and exposure simulation analysis for cediranib
@nl
type
label
Population pharmacokinetic and ...... udies in patients with cancer.
@en
Population pharmacokinetic and exposure simulation analysis for cediranib
@nl
prefLabel
Population pharmacokinetic and ...... udies in patients with cancer.
@en
Population pharmacokinetic and exposure simulation analysis for cediranib
@nl
P2093
P2860
P356
P1476
Population pharmacokinetic and ...... udies in patients with cancer.
@en
P2093
Anja Henningsson
Eric Masson
Jianguo Li
Nidal Al-Huniti
Weifeng Tang
P2860
P304
P356
10.1111/BCP.13266
P407
P577
2017-02-18T00:00:00Z